These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3905747)

  • 21. [The effect of ultrasonic oscillations and amphotericin B on the ultrastructure of yeast-like fungi in the genus Candida].
    Romanenko IM
    Vestn Dermatol Venerol; 1990; (12):27-9. PubMed ID: 2094097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined activity of minocycline and amphotericin B in vitro against medically important yeasts.
    Lew MA; Beckett KM; Levin MJ
    Antimicrob Agents Chemother; 1978 Sep; 14(3):465-9. PubMed ID: 708025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strong correlation between the antifungal effect of amphotericin B and its inhibitory action on germ-tube formation in a Candida albicans URA⁺ strain.
    Guirao-Abad JP; González-Párraga P; Argüelles JC
    Int Microbiol; 2015 Mar; 18(1):25-31. PubMed ID: 26415664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonism by sterols of the action of amphotericin and filipin on the release of potassium ions from Candida albicans and Mycoplasma mycoides subsp. capri.
    Archer DB; Gale EF
    J Gen Microbiol; 1975 Sep; 90(1):187-90. PubMed ID: 1100776
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparative in vitro study of amphotericin B 1 clotrimazole and 5-fluorocytosine against clinically isolated yeasts.
    Hamilton-Miller JM
    Sabouraudia; 1972 Nov; 10(3):276-83. PubMed ID: 4565443
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of antineoplastic agents on the growth and ultrastructure of Candida albicans.
    Ghannoum MA; Al-Khars A
    Mykosen; 1984 Sep; 27(9):452-64. PubMed ID: 6438503
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal drug susceptibility of oral Candida albicans isolates may be associated with apoptotic responses to Amphotericin B.
    Yang C; Gong W; Lu J; Zhu X; Qi Q
    J Oral Pathol Med; 2010 Feb; 39(2):182-7. PubMed ID: 19656268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The polyene macrolide antibiotics.
    Kerridge D
    Postgrad Med J; 1979 Sep; 55(647):653-6. PubMed ID: 392481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal property of hibicuslide C and its membrane-active mechanism in Candida albicans.
    Hwang JH; Jin Q; Woo ER; Lee DG
    Biochimie; 2013 Oct; 95(10):1917-22. PubMed ID: 23816874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-vitro activity of cilofungin (LY121019) in comparison with amphotericin B.
    Meunier F; Lambert C; Van der Auwera P
    J Antimicrob Chemother; 1989 Sep; 24(3):325-31. PubMed ID: 2681118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of treatment with mepartricin on the plasma androgen and gonadotropin concentrations in subjects with benign prostatic hypertrophy].
    Sciarra F; Bianchi P; Toscano V
    Minerva Urol Nefrol; 1988; 40(2 Suppl):10-2. PubMed ID: 2460936
    [No Abstract]   [Full Text] [Related]  

  • 33. Do quinolones really augment the antifungal effect of amphotericin B in vitro?
    Overbeek BP; Rozenberg-Arska M; Verhoef J
    Drugs Exp Clin Res; 1985; 11(11):745-6. PubMed ID: 3915463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
    Kucukates E; Erturan Z; Susever S; Yegenoglu Y
    APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
    El-Azizi M; Farag N; Khardori N
    Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical pharmacologic aspects of mepartricin. Possible pharmacologic interference with digitaloids and anticoagulants].
    Costa FV
    Minerva Urol Nefrol; 1988; 40(2 Suppl):5-6. PubMed ID: 2460951
    [No Abstract]   [Full Text] [Related]  

  • 37. The mode of action of polyene antibiotics; induced potassium leakage in Candida albicans.
    Hammond SM; Lambert PA; Kliger BN
    J Gen Microbiol; 1974 Apr; 81(2):325-30. PubMed ID: 4599408
    [No Abstract]   [Full Text] [Related]  

  • 38. Uptake and killing of Candida by human peritoneal macrophages and amphotericin B.
    Linde HJ; Stille W; Shah PM
    Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):79-84. PubMed ID: 8007745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluconazole vs amphotericin B: "in vitro" comparative evaluation of the minimal inhibitory concentration (MIC) against yeasts isolated from AIDS patients.
    Lombardi G; Gramegna G; Cavanna C; Michelone G
    Microbiologica; 1990 Jul; 13(3):201-6. PubMed ID: 2273982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Activity of Fungichromin against the Formation of Candida albicans Biofilm.
    An D; Wang X; Li J; Jiang S; Ma X; Zhang H; Shi H; Sun H; Ye L; Li J
    Biol Pharm Bull; 2016 Dec; 39(12):1948-1954. PubMed ID: 27615430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.